Last reviewed · How we verify

NCT05194241

One MORE for Chronic Pain

Completed NA Last updated 15 March 2023
What this trial tests

NA trial testing One MORE in Chronic Pain in 40 participants. Completed in 27 November 2022.

Timeline
18 November 2021
Primary endpoint
27 November 2022
27 November 2022

Quick facts

Lead sponsorUniversity of Utah
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment40
Start date18 November 2021
Primary completion27 November 2022
Estimated completion27 November 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Utah

Who can join

18 and older, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be a single-site, two-arm randomized controlled trial conducted among chronic pain patients. Chronic pain patients will be randomized by a computer-generated randomization schedule with simple random allocation (1:1) to either One MORE or a wait-list control condition (WLC). One MORE will be delivered individually via a HIPAA compliant virtual meeting platform.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A Single-Session, 2-Hour Version of Mindfulness-Oriented Recovery Enhancement (One MORE) Improves Chronic Pain Patients' Pain-Related Outcomes Through 3-Month Follow-Up in a Randomized Controlled Trial.
    Hanley AW, Lingard A, Garland EL. · · 2024 · cited 3× · PMID 38588552 · DOI 10.1089/jicm.2023.0501

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other University of Utah trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05194241.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing